Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for Documentation of Analytical Calculations and Worksheets – V 2.0

Posted on By

Analytical Method Development: SOP for Documentation of Analytical Calculations and Worksheets – V 2.0

Standard Operating Procedure for Documentation of Analytical Calculations and Worksheets in Analytical Method Development


Department Analytical Method Development
SOP No. SOP/AMD/399/2025
Supersedes SOP/AMD/399/2022
Page No. Page 1 of 13
Issue Date 01/06/2025
Effective Date 03/06/2025
Review Date 01/06/2026

1. Purpose

This SOP defines the procedure for recording analytical calculations and completing raw data worksheets to ensure data accuracy, traceability, and compliance with Good Documentation Practices

(GDP) during Analytical Method Development (AMD).

2. Scope

This SOP applies to all analytical calculations and worksheets generated during the development, optimization, verification, and validation of analytical methods in the AMD department.

3. Responsibilities

  • Analyst: Accurately documents calculations and raw data on pre-approved formats.
  • Reviewer: Verifies all entries and calculations for correctness and compliance.
  • QA Personnel: Audits documentation for adherence to GDP and internal SOPs.
See also  Analytical Method Development: SOP for Qualification of Working Standards - V 2.0

4. Accountability

The Head of AMD is accountable for the integrity, review, and archival of all analytical worksheets and calculations maintained under this SOP.

5. Procedure

5.1 Preparation of Analytical Worksheets

  1. Use only controlled and numbered worksheets issued by the QA department (refer Annexure-1).
  2. Enter the study ID, method number, analyst name, and date at the top of the sheet.
  3. Fill in test conditions, sample details, instrument ID, and analysis date.

5.2 Documentation of Raw Data

  1. Record all raw data (e.g., weights, volumes, instrument readings) in blue/black indelible ink.
  2. Do not overwrite; strike through incorrect entries with a single line, write correct data nearby, and initial/date the correction.
  3. Attach printouts (chromatograms, spectra, etc.) with analyst signature and date on each page.

5.3 Calculations and Formula Usage

  1. Use approved formulae specified in the test method.
  2. Show all steps of calculations including units (e.g., mg/mL, %, ppm).
  3. Include dilution factors, purity corrections, and standardization values where applicable.
  4. Round off values as per SOP on significant figures (refer SOP/AMD/212/2025).
See also  Analytical Method Development: SOP for Identification of Cream Base Components via FTIR - V 2.0

5.4 Review and Cross-Verification

  1. Second analyst or reviewer must cross-check 100% of calculations.
  2. Reviewer to initial and date the reviewed pages after verification.
  3. Any discrepancy must be investigated and documented with appropriate justification.

5.5 Archival of Worksheets

  1. After QA review, compile the complete set of worksheets and associated data in a labeled folder.
  2. Archive as per document control SOP (SOP/QA/001/2025) in the AMD record room.
  3. Retain all documentation for a minimum period of five years or as per regulatory requirement.

6. Abbreviations

  • AMD: Analytical Method Development
  • GDP: Good Documentation Practices
  • QA: Quality Assurance
  • ID: Identification

7. Documents

  1. Controlled Worksheet Template – Annexure-1
  2. Calculation Formula Sheet – Annexure-2
  3. Reviewer Checklist – Annexure-3

8. References

  • ICH Q10 – Pharmaceutical Quality System
  • WHO TRS 986 Annex 3 – GMP for Pharmaceuticals
  • FDA 21 CFR Part 211 – cGMP Requirements
  • SOP/AMD/212/2025 – Guidelines on Rounding and Significant Figures
See also  Analytical Method Development: SOP for Preparing Calibration Curve Using External Standards - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name Shruti Sharma Priya Nair Dr. Harshita Goyal
Designation Analyst – AMD QA Reviewer Head – AMD
Department Analytical Method Development Quality Assurance Analytical Method Development

11. Annexures

Annexure-1: Controlled Worksheet Template

Includes fields for test ID, method title, equipment ID, sample ID, dilution factors, raw data, and calculation steps.

Annexure-2: Calculation Formula Sheet

Calculation Formula Example
Assay (Sample Area / Std Area) × Std Potency × Dilution Factor (1200 / 1250) × 99.8 × 2 = 191.52

Annexure-3: Reviewer Checklist

  • Worksheet signed and dated by analyst
  • All calculations verified
  • Corrections compliant with GDP
  • Attached chromatograms, spectra, instrument logs

Revision History:

Revision Date Revision No. Details Reason Approved By
01/06/2025 2.0 Inclusion of controlled worksheet format and verification checklist Annual SOP Review Dr. Harshita Goyal
20/07/2022 1.0 Initial Release New SOP QA Head
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Analytical Method Development: SOP for Qualification of Reference Standards and Working Standards – V 2.0
Next Post: Analytical Method Development: SOP for Method Development for Stability Indicating Assays – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version